SeriousConflict
Both carbamazepine and St. John's Wort are potent CYP3A4 inducers. Combining them creates unpredictable effects on drug metabolism, potentially causing auto-induction of carbamazepine's own metabolism, leading to subtherapeutic anticonvulsant levels and increased seizure risk.
Recommendation: Avoid combining St. John's Wort with carbamazepine. The dual CYP induction creates unpredictable drug levels and may compromise seizure control. Monitor carbamazepine levels closely if the combination cannot be avoided.
ModerateSynergy
Carbamazepine depletes folate through enzyme induction effects on folate metabolism. Folate deficiency during carbamazepine therapy can cause megaloblastic anemia and is particularly concerning in women of childbearing age due to increased neural tube defect risk during pregnancy.
Recommendation: Supplement with folic acid (1mg/day) during carbamazepine therapy, particularly for women of childbearing age. Higher doses (4mg/day) are recommended periconceptionally for women on antiepileptic drugs.
ModerateSynergy
Carbamazepine induces CYP enzymes that accelerate vitamin D metabolism, leading to deficiency, reduced calcium absorption, and increased osteoporosis risk. Vitamin D supplementation is recommended for all patients on chronic carbamazepine therapy.
Recommendation: Supplement with vitamin D3 (1000-4000 IU/day) during long-term carbamazepine therapy. Monitor 25-OH vitamin D levels and adjust doses accordingly. Higher doses may be needed due to accelerated vitamin D catabolism.
ModerateCaution
Both are potent CYP enzyme inducers that affect each other's metabolism. Phenytoin can decrease carbamazepine levels, while carbamazepine can decrease phenytoin levels, making dose optimization challenging.
Recommendation: Monitor serum levels of both drugs closely when used together. Dose adjustments are frequently needed. Therapeutic drug monitoring is essential.
ModerateCaution
Carbamazepine reduces folate levels by inhibiting intestinal absorption and increasing hepatic folate catabolism. Folate deficiency can cause megaloblastic anemia. However, high-dose folate supplementation may reduce carbamazepine levels.
Recommendation: Low-dose folate supplementation (400-1000mcg/day) is generally recommended during carbamazepine therapy. Avoid high-dose folate (>5mg) as it may reduce carbamazepine levels. Monitor CBC and drug levels.
ModerateSynergy
Long-term carbamazepine therapy is associated with adverse bone-mineral effects and higher fracture risk, especially when vitamin D or calcium intake is low. Calcium intake is part of standard bone-health prevention for people on chronic antiseizure medication. This is a long-term risk issue rather than an acute same-day interaction.
Recommendation: Make sure your total calcium intake from diet and supplements is appropriate while taking carbamazepine long term. Ask about vitamin D testing and bone-density screening if you have additional fracture risks. Do not take very high calcium doses unless prescribed because excess calcium can raise kidney-stone and cardiovascular concerns in some people.
ModerateSynergy
Carbamazepine and other enzyme-inducing antiseizure drugs have been linked with lower vitamin B6 status. Low B6 can contribute to high homocysteine and may worsen neuropathy or other deficiency symptoms in vulnerable patients. The concern is greatest with long-term therapy, restricted diets, alcohol misuse, pregnancy, or multiple B-vitamin deficiencies.
Recommendation: Ask about checking B-vitamin status or homocysteine if you take carbamazepine long term or have neuropathy, anemia, or cardiovascular risk factors. Use standard-dose B6 unless your clinician recommends otherwise. Avoid chronic high-dose B6 because it can itself cause nerve toxicity.
SeriousConflict
Ginkgo biloba has case reports of precipitating seizures in people with previously controlled epilepsy. That directly conflicts with carbamazepine's purpose when it is being used for seizure control, and it may also complicate care in people taking carbamazepine for neuralgia or mood stabilization who have seizure vulnerability. The risk is avoidable and is higher with a seizure history, missed antiseizure doses, sleep deprivation, alcohol, or products with poorly controlled ginkgotoxin content.
Recommendation: Avoid ginkgo biloba if you take carbamazepine for epilepsy or have any seizure history. If you already started ginkgo and notice breakthrough seizures, auras, twitching, confusion spells, or loss of awareness, stop it and seek medical advice urgently. Do not change carbamazepine dosing without your prescriber.
NutriStack